Insulet (PODD)
(Delayed Data from NSDQ)
$175.57 USD
-8.71 (-4.73%)
Updated May 8, 2024 04:00 PM ET
After-Market: $175.63 +0.06 (0.03%) 7:44 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 40% (101 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.37 | 1.69 | 9.99 |
Current Quarter Estimate | 0.39 | 5.88 | 57.00 |
Year Ago Quarter Estimate | 0.23 | 4.88 | 52.54 |
Next Quarter Estimate | 0.57 | 7.06 | 61.00 |
Next Year Estimate | 3.87 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 12.00 | 17.70 | 15.67 |
Next Year | 25.65 | 23.90 | 9.31 |
Last 5 Years | 114.70 | 4.00 | 8.10 |
Next 5 Years | 18.10 | 10.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 67.75 | -13.85 |
Price/Book (MRQ) | 17.56 | 1.92 |
Price/Cash Flow (MRFY) | 48.56 | 11.24 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 12.16% | 9.56% |
Return on Equity (TTM) | 32.19% | 13.06% |
Debt to Equity (MRQ) | NA | 26.41 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.